MedTrace Logo

Investigation of Mortality, Morbidity and Risk Factors After Pediatric Liver Transplantation

NCT04778735 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 207

Last updated 2022-04-06

No results posted yet for this study

Summary

The Department of Organ Transplantation in Memorial Hospitals has started Pediatric Liver Transplantation Program in 2016. As of the end of 2020, we have performed 169 pediatric liver transplantation. The aim of this study is to investigate the overall mortality, morbidity and risk factors for adverse outcomes in pediatric liver transplantation. The patients' records will be retrospectively scanned and the data will be gathered.

Conditions

  • Liver Transplantation
  • Liver Diseases
  • Biliary Atresia
  • Morbidity;Infant
  • Mortality

Interventions

PROCEDURE

Liver Transplantation

Liver Transplantation is performed under spesific conditions to increase the life time of patients with liver diseases.

Sponsors & Collaborators

  • Memorial Bahçelievler Hospital

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
0 Months
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-24
Primary Completion
2022-04-01
Completion
2022-04-04

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04778735 on ClinicalTrials.gov